최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기International journal of molecular sciences, v.17 no.11, 2016년, pp.1798 -
Kim, Ji-Woong , Kim, Hong-Il , Kim, Jong-Hyeon , Kwon, O-Chul , Son, Eun-Suk , Lee, Chang-Soo , Park, Young-Jin
Ganoderma lucidum, a species of the Basidiomycetes class, has been attracting international attention owing to its wide variety of biological activities and great potential as an ingredient in skin care cosmetics including “skin-whitening” products. However, there is little information available on ...
1. Slominski A. Tobin D.J. Shibahara S. Wortsman J. Melanin pigmentation in mammalian skin and its hormonal regulation Physiol. Rev. 2004 84 1155 1228 10.1152/physrev.00044.2003 15383650
2. Slominski A. Wortsman J. Plonka P.M. Schallreuter K.U. Paus R. Tobin D.J. Hair follicle pigmentation J. Investig. Dermatol. 2005 124 13 21 10.1111/j.0022-202X.2004.23528.x 15654948
3. Costin G.E. Hearing V.J. Human skin pigmentation: Melanocytes modulate skin color in response to stress FASEB J. 2007 21 976 994 10.1096/fj.06-6649rev 17242160
4. Slominski A. Zmijewski M.A. Pawelek J. l -Tyrosine and l -dihydroxyphenylalanine as hormone-like regulators of melanocyte functions Pigment Cell Melanoma Res. 2012 25 14 27 10.1111/j.1755-148X.2011.00898.x 21834848
5. Videira I.F. Moura D.F. Magina S. Mechanisms regulating melanogenesis An. Bras. Dermatol. 2013 88 76 83 10.1590/S0365-05962013000100009 23539007
6. Slominski R.M. Zmijewski M.A. Slominski A.T. The role of melanin pigment in melanoma Exp. Dermatol. 2015 24 258 259 10.1111/exd.12618 25496715
7. Sánchez-Ferrer Á. Rodríguez-López J.N. García-Cánovas F. García-Carmona F. Tyrosinase: A comprehensive review of its mechanism Biochem. Biophys. Acta 1995 1247 1 11 10.1016/0167-4838(94)00204-T 7873577
8. Jimbow K. Obata H. Pathak M.A. Fitzpatrick T.B. Mechanism of depigmentation by hydroquinone J. Investig. Dermatol. 1974 62 436 449 10.1111/1523-1747.ep12701679 4206837
9. Pathak M.A. Fitzpatrick T.B. Kraus E.W. Usefulness of retinoic acid in the treatment of melasma J. Am. Acad. Dermatol. 1986 15 894 899 10.1016/S0190-9622(86)70247-8 3534025
10. Schallreuter K.U. Wood J.W. A possible mechanism of action for azelaic acid in the human epidermis Arch. Dermatol. Res. 1990 282 168 171 10.1007/BF00372617 2114832
11. Cabanes J. Chazarra S. García-Carmona F. Kojic acid, a cosmetic skin whitening agent, is a slow-binding inhibitor of catecholase activity of tyrosinase J. Pharm. Pharmacol. 1994 46 982 985 10.1111/j.2042-7158.1994.tb03253.x 7714722
12. Chang T.S. An updated review of tyrosinase inhibitors Int. J. Mol. Sci. 2009 10 2440 2475 10.3390/ijms10062440 19582213
13. Maeda K. Fukuda M. Arbutin: Mechanism of its depigmenting action in human melanocyte culture J. Pharmacol. Exp. Ther. 1996 276 765 769 8632348
14. Palumbo A. d’Ischia M. Misuraca G. Prota G. Mechanism of inhibition of melanogenesis by hydroquinone Biochim. Biophys. Acta 1991 1073 85 90 10.1016/0304-4165(91)90186-K 1899343
15. Decaprio A.P. The toxicology of hydroquinone—Relevance to occupational and environmental exposure Crit. Rev. Toxicol. 1999 29 283 330 10.1080/10408449991349221 10379810
16. McGregor D. Hydroquinone: An evaluation of the human risks from its carcinogenic and mutagenic properties Crit. Rev. Toxicol. 2007 37 887 914 10.1080/10408440701638970 18027166
17. Parvez S. Kang M. Chung H.S. Bae H.S. Naturally occurring tyrosinase inhibitors: Mechanism and applications in skin health, cosmetics and agriculture industries Phytother. Res. 2007 21 805 816 10.1002/ptr.2184 17605157
18. Aburjai T. Natsheh F.M. Palnts used in cosmetics Phytother. Res. 2003 17 987 1000 10.1002/ptr.1363 14595575
19. Wang K.H. Lin R.D. Hsu F.L. Huang Y.H. Chang H.C. Huang C.Y. Lee M.H. Cosmetic applications of selected traditional Chinese herbal medicines J. Ethnopharmacol. 2006 106 353 359 10.1016/j.jep.2006.01.010 16497459
21. Chang S.T. Miles P.G. Mushrooms: Cultivation, Nutritional Value, Medicinal Effect, and Environmental Impact 2nd ed. CRC Press Boca Raton, FL, USA Taylor & Francis Boca Raton, FL, USA 2003 11 12
22. Wachtel-Galor S. Yuen J. Buswell J.A. Benzie I.F.F. Ganoderma lucidum (Lingzhi or Reishi) Herbal Medicine: Biomolecular and Clinical Aspects 2nd ed. Benzie I.F.F. Watchel-Galor S. CRC Press Boca Raton, FL, USA Taylor & Francis Boca Raton, FL, USA 2011 1 31
23. Boh B. Berovic M. Zhang J. Zhi-Bin L. Ganoderma lucidum and its pharmaceutically active compounds Biotechnol. Annu. Rev. 2007 13 265 301 17875480
24. Sanodiya B.S. Thakur G.S. Baghel R.K. Prasad G.B. Bisen P.S. Ganoderma lucidum : A potent pharmacological macrofungus Curr. Pharm. Biotechnol. 2009 10 717 742 10.2174/138920109789978757 19939212
25. Chien C.C. Tsai M.L. Chen C.C. Chang S.J. Tseng C.H. Effects on tyrosinase activity by the extracts of Ganoderma lucidum and related mushrooms Mycopathologia 2008 166 117 120 10.1007/s11046-008-9128-x 18459064
26. Min B.S. Nakamura N. Miyashiro H. Bae K.W. Hattori M. Triterpenes from the spores of Ganoderma lucidum and their inhibitory activity against HIV-1 protease Chem. Pharm. Bull. 1998 46 1607 1612 10.1248/cpb.46.1607 9810695
27. Min B.S. Gao J.J. Hattori M. Lee H.K. Kim Y.H. Anticomplement activity of terpenoids from the spores of Ganoderma lucidum Planta Med. 2001 67 811 814 10.1055/s-2001-18854 11745016
28. Li B. Lee D.S. Kang Y. Yao N.Q. An R.B. Kim Y.C. Protective effect of ganodermanondiol isolated from the Lingzhi mushroom against tert -butyl hydroperoxide-induced hepatotoxicity through Nrf2-mediated antioxidant enzymes Food Chem. Toxicol. 2013 53 317 324 10.1016/j.fct.2012.12.016 23266269
29. Bickers D.R. Athar M. Oxidative stress in the pathogenesis of skin disease J. Investig. Dermatol. 2006 126 2565 2575 10.1038/sj.jid.5700340 17108903
30. Maeda K. Yokokawa Y. Hatao M. Naganuma M. Tomita Y. Comparison of the melanogenesis in human black and light brown melanocytes J. Dermatol. Sci. 1997 14 199 206 10.1016/S0923-1811(96)00575-0 9138477
31. Fang D. Kute T. Setaluri V. Regulation of tyrosinase-related protein-2 (TYRP2) in human melanocytes: Relationship to growth and morphology Pigment Cell Melanoma Res. 2001 14 132 139 10.1034/j.1600-0749.2001.140209.x
32. Shibahara S. Yasumoto K.I. Amae S. Udono T. Watanabe K.I. Saito H. Takeda K. Regulation of pigment cell-specific gene expression by MITF Pigment Cell Melanoma Res. 2000 13 98 102 10.1034/j.1600-0749.13.s8.18.x
33. Luger T.A. Scholzen T. Grabbe S. The role of alpha-melanocyte-stimulating hormone in cutaneous biology J. Investig. Dermatol. Symp. Proc. 1997 2 87 93 10.1038/jidsymp.1997.17 9487022
34. Buscà R. Ballotti R. Cyclic AMP a key messenger in the regulation of skin pigmentation Pigment Cell Melanoma Res. 2000 13 60 69 10.1034/j.1600-0749.2000.130203.x
35. Bentley N.J. Eisen T. Goding C.R. Melanocyte-specific expression of the human tyrosinase promoter: Activation by the microphthalmia gene product and role of the initiator Mol. Cell. Biol. 1994 14 7996 8006 10.1128/MCB.14.12.7996 7969139
36. Yavuzer U. Keenan E. Lowings P. Vachtenheim J. Currie G. Goding C.R. The Microphthalmia gene product interacts with the retinoblastoma protein in vitro and is a target for deregulation of melanocyte-specific transcription Oncogene 1995 10 123 134 7824265
37. Bertolotto C. Bille K. Ortonne J.P. Ballotti R. Regulation of tyrosinase gene expression by cAMP in B16 melanoma cells involves two CATGTG motifs surrounding the TATA box: Implication of the microphthalmia gene product J. Cell Biol. 1996 134 747 755 10.1083/jcb.134.3.747 8707852
38. Kim A. Yim N.H. Im M. Jung Y.P. Liang C. Cho W.K. Ma J.Y. Ssanghwa-tang, an oriental herbal cocktail, exerts anti-melanogenic activity by suppression of the p38 MAPK and PKA signaling pathways in B16F10 cells BMC Complement. Altern. Med. 2013 13 214 10.1186/1472-6882-13-214 23981281
39. Chan C.F. Huang C.C. Lee M.Y. Lin Y.S. Fermented broth in tyrosinase- and melanogenesis inhibition Molecules 2014 19 13122 13135 10.3390/molecules190913122 25255749
40. Jang J.Y. Kim H.N. Kim Y.R. Choi W.Y. Choi Y.H. Shin H.K. Choi B.T. Partially purified components of Nardostachys chinensis suppress melanin synthesis through ERK and Akt signaling pathway with cAMP down-regulation in B16F10 cells J. Ethnopharmacol. 2011 137 1207 1214 10.1016/j.jep.2011.07.047 21816215
41. Imokawa G. Ishida K. Inhibitors of intracellular signaling pathways that lead to stimulated epidermal pigmentation: Perspective of anti-pigmenting agents Int. J. Mol. Sci. 2014 15 8293 8315 10.3390/ijms15058293 24823877
42. Mosmann T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays J. Immunol. Methods 1983 65 55 63 10.1016/0022-1759(83)90303-4 6606682
43. Chan Y.Y. Kim K.H. Cheah S.H. Inhibitory effects of Sargassum polycystum on tyrosinase activity and melanin formation in B16F10 murine melanoma cells J. Ethnopharmacol. 2011 137 1183 1188 10.1016/j.jep.2011.07.050 21810462
44. Saxena S. Andersen R. Maibach H.I. What do we know about depigmenting agents? Cosmet. Toilet. 2015 130 26 29
45. Valverde P. Benedito E. Solano F. Oaknin S. Lozano J.A. García-Borrón J.C. Melatonin antagonizes α-melanocyte-stimulating hormone enhancement of melanogenesis in mouse melanoma cells by blocking the hormone-induced accumulation of the C Locus tyrosinase Eur. J. Biochem. 1995 232 257 263 10.1111/j.1432-1033.1995.tb20807.x 7556159
46. Kim T.K. Lin Z. Tidwell W.J. Li W. Slominski A.T. Melatonin and its metabolites accumulate in the human epidermis in vivo and inhibit proliferation and tyrosinase activity in epidermal melanocytes in vitro Mol. Cell. Endocrinol. 2015 404 1 8 10.1016/j.mce.2014.07.024 25168391
47. Roh E. Jeong I.Y. Shin H.E. Song S.G. Kim N.D. Jung S.H. Hong J.T. Lee S.H. Han S.B. Kim Y.S. Downregulation of melanocyte-specific facultative melanogenesis by 4-hydroxy-3-methoxycinnamaldehyde acting as a cAMP antagonist J. Investig. Dermatol. 2014 134 551 553 10.1038/jid.2013.341 23934066
48. Lee H.J. Lee W.J. Chang S.E. Lee G.Y. Hesperidin, a popular antioxidant inhibits melanogenesis via Erk1/2 mediated MITF degradation Int. J. Mol. Sci. 2015 16 18384 18395 10.3390/ijms160818384 26262610
49. Zhu P.Y. Yin W.H. Wang M.R. Dang Y.Y. Ye X.Y. Andrographolide suppresses melanin synthesis through Akt/GSK3β/β-catenin signal pathway J. Dermatol. Sci. 2015 79 74 83 10.1016/j.jdermsci.2015.03.013 25869056
50. Chun H.J. Choi W.H. Baek S.H. Woo W.H. Effect of quercetin on melanogenesis in melan-a melanocyte cells Korean J. Pharmacogn. 2002 33 245 251
51. Chun H.J. Hwang S.G. Kim C.K. Jeon B.H. Baek S.H. Woo W.H. In vitro modulation of proliferation and melanization of B16/F10 melanoma cells by quercetin J. Pharm. Soc. Korea 2002 46 75 80
52. Kim Y.J. Hyperin and quercetin modulate oxidative stress-induced melanogenesis Biol. Pharm. Bull. 2012 35 2023 2027 10.1248/bpb.b12-00592 22971648
53. Takekoshi S. Matsuzaki K. Kitatani K. Quercetin stimulates melanogenesis in hair follicle melanocyte of the mouse Tokai J. Exp. Clin. Med. 2013 38 129 134 24318284
54. Nagata H. Takekoshi S. Takeyama R. Homma T. Osamura R.Y. Quercetin enhances melanogenesis by increasing the activity and synthesis of tyrosinase in human melanoma cells and normal human melanocytes Pigment Cell Melanoma Res. 2004 17 66 73 10.1046/j.1600-0749.2003.00113.x
55. Slominski A. Zbytek B. Slominski R. Inhibitors of melanogenesis increase toxicity of cyclophosphamide and lymphocytes against melanoma cells Int. J. Cancer 2009 124 1470 1477 10.1002/ijc.24005 19085934
56. Slominski A. Kim T.K. Brożyna A.A. Janjetovic Z. Brooks D.L.P. Schwab L.P. Skobowiat C. Jóźwicki W. Seagroves T.N. The role of melanogenesis in regulation of melanoma behavior: Melanogenesis leads to stimulation of HIF-1α expression and HIF-dependent attendant pathways Arch. Biochem. Biophys. 2014 563 79 93 10.1016/j.abb.2014.06.030 24997364
57. Brożyna A.A. Jóźwicki W. Roszkowski K. Filipiak J. Slominski A.T. Melanin content in melanoma metastases affects the outcome of radiotherapy Oncotarget 2016 7 17844 17853 10.18632/oncotarget.7528 26910282
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
오픈액세스 학술지에 출판된 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.